MMP9 and neoplasm: Thus far, ECM remodeling enzymes, such as MMP9, CathG, PR3 and NE, have been considered as pro-tumor factors in virtue of their ability to modify the ECM structure, facilitate tumor cell metastasis and release growth factors sequestered to components of the ECM that can further fuel the tumor growth.